PP1α, PP1β and Wip-1 regulate H4S47 phosphorylation and deposition of histone H3 variant H3.3

Nucleic Acids Research

Volumn 41, Issue 17, 2013, Pages 8085-8093

  Zhang, Hui ^a   Wang, Zhiquan ^a   Zhang, Zhiguo ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; DAXX PROTEIN; HISTONE H3; HISTONE H3.3; HISTONE H4; HISTONE H4 SERINE 47; P21 ACTIVATED KINASE 2; PHOSPHATASE; PROTEIN HIRA; PROTEIN PP1ALPHA; PROTEIN PP1BETA; PROTEIN WIP1; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CHROMATIN; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME PHOSPHORYLATION; HISTONE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PROTEIN INTERACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL CYCLE PROTEINS; CELL LINE; HELA CELLS; HISTONE CHAPERONES; HISTONES; HUMANS; NUCLEAR PROTEINS; P21-ACTIVATED KINASES; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PROTEIN PHOSPHATASE 1; SERINE; TRANSCRIPTION FACTORS;

EID: 84884950319     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt583     Document Type: Article

References (37)

1. Talbert,P.B. and Henikoff,S. (2010) Histone variants-ancient wrap artists of the epigenome. Nat. Rev. Mol. Cell. Biol., 11, 264-275.
2. Burgess,R.J. and Zhang,Z. (2013) Histone chaperones in nucleosome assembly and human disease. Nat. Struct. Mol. Biol., 20, 14-22.
3. Ransom,M., Dennehey,B. and Tyler,J.K. (2010) Chaperoning histones during repair and replication. Cell, 140, 183-195.
4. Elsaesser,S.J., Goldberg,A.D. and Allis,C.D. (2010) New functions for an old variant: no substitute for histone H3.3. Curr. Opin. Genet. Dev., 20, 1-8.
5. Szenker,E., Ray-Gallet,D. and Almouzni,G. (2011) The double face of the histone variant H3.3. Cell Res., 21, 421-434.
6. Szenker,E., Ray-Gallet,D. and Almouzni,G. (2011) The double face of the histone variant H3.3. Cell Res., 21, 421-434.
7. Sakai,A., Schwartz,B.E., Goldstein,S. and Ahmad,K. (2009) Transcriptional and developmental functions of the H3.3 histone variant in Drosophila. Curr. Biol., 19, 1816-1820.
8. Couldrey,C., Carlton,M.B., Nolan,P.M., Colledge,W.H. and Evans,M.J. (1999) A retroviral gene trap insertion into the histone 3.3A gene causes partial neonatal lethality, stunted growth, neuromuscular deficits and male sub-fertility in transgenic mice. Hum. Mol. Genet., 8, 2489-2495.
9. Ahmad,K. and Henikoff,S. (2002) The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. Mol. Cell., 9, 1191-1200. (Pubitemid 34722299)
10. Schwartz,B.E. and Ahmad,K. (2005) Transcriptional activation triggers deposition and removal of the histone variant H3.3. Genes Dev., 19, 804-814.
11. Mito,Y., Henikoff,J.G. and Henikoff,S. (2005) Genome-scale profiling of histone H3.3 replacement patterns. Nat. Genet., 37, 1090-1097. (Pubitemid 41486661)
12. Jin,C., Zang,C., Wei,G., Cui,K., Peng,W., Zhao,K. and Felsenfeld,G. (2009) H3.3/H2A.Z double variant-containing nucleosomes mark 'nucleosome-free regions' of active promoters and other regulatory regions. Nat. Genet., 41, 941-945.
13. Goldberg,A.D., Banaszynski,L.A., Noh,K.M., Lewis,P.W., Elsaesser,S.J., Stadler,S., Dewell,S., Law,M., Guo,X., Li,X. et al. (2010) Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell, 140, 678-691.
14. Hake,S.B., Garcia,B.A., Kauer,M., Baker,S.P., Shabanowitz,J., Hunt,D.F. and Allis,C.D. (2005) Serine 31 phosphorylation of histone variant H3.3 is specific to regions bordering centromeres in metaphase chromosomes. Proc. Natl Acad. Sci. USA, 102, 6344-6349. (Pubitemid 40617445)
15. Santenard,A., Ziegler-Birling,C., Koch,M., Tora,L., Bannister,A.J. and Torres-Padilla,M.E. (2010) Heterochromatin formation in the mouse embryo requires critical residues of the histone variant H3.3. Nat. Cell. Biol., 12, 853-862.
16. Wu,G., Broniscer,A., McEachron,T.A., Lu,C., Paugh,B.S., Becksfort,J., Qu,C., Ding,L., Huether,R., Parker,M. et al. (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet., 44, 251-253.
17. Sturm,D., Witt,H., Hovestadt,V., Khuong-Quang,D.A., Jones,D.T., Konermann,C., Pfaff,E., Tonjes,M., Sill,M., Bender,S. et al. (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell, 22, 425-437.
18. Ray-Gallet,D., Quivy,J.P., Scamps,C., Martini,E.M., Lipinski,M. and Almouzni,G. (2002) HIRA is critical for a nucleosome assembly pathway independent of DNA synthesis. Mol. Cell, 9, 1091-1100. (Pubitemid 34626677)
19. Tagami,H., Ray-Gallet,D., Almouzni,G. and Nakatani,Y. (2004) Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell, 116, 51-61. (Pubitemid 38156183)
20. Campos,E.I. and Reinberg,D. (2010) New chaps in the histone chaperone arena. Genes Dev., 24, 1334-1338.
21. Drane,P., Ouararhni,K., Depaux,A., Shuaib,M. and Hamiche,A. (2010) The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev., 24, 1253-1265.
22. Elsasser,S.J., Huang,H., Lewis,P.W., Chin,J.W., Allis,C.D. and Patel,D.J. (2012) DAXX envelops a histone H3.3-H4 dimer for H3.3-specific recognition. Nature, 491, 560-565.
23. Liu,C.P., Xiong,C., Wang,M., Yu,Z., Yang,N., Chen,P., Zhang,Z., Li,G. and Xu,R.M. (2012) Structure of the variant histone H3.3-H4 heterodimer in complex with its chaperone DAXX. Nat. Struct. Mol. Biol., 19, 1287-1292.
24. English,C.M., Adkins,M.W., Carson,J.J., Churchill,M.E. and Tyler,J.K. (2006) Structural basis for the histone chaperone activity of Asf1. Cell, 127, 495-508. (Pubitemid 44647420)
25. Zhang,H., Han,J., Kang,B., Burgess,R. and Zhang,Z. (2012) Human histone acetyltransferase 1 protein preferentially acetylates H4 histone molecules in H3.1-H4 over H3.3-H4. J. Biol. Chem., 287, 6573-6581.
26. Kang,B., Pu,M., Hu,G., Wen,W., Dong,Z., Zhao,K., Stillman,B. and Zhang,Z. (2011) Phosphorylation of H4 Ser 47 promotes HIRA-mediated nucleosome assembly. Genes Dev., 25, 1359-1364.
27. Bokoch,G.M. (2003) Biology of the p21-activated kinases. Annu. Rev. Biochem., 72, 743-781. (Pubitemid 36930459)
28. Sells,M.A. and Chernoff,J. (1997) Emerging from the Pak: the p21-activated protein kinase family. Trends Cell Biol., 7, 162-167. (Pubitemid 27135576)
29. Kumar,R. and Vadlamudi,R.K. (2002) Emerging functions of p21-activated kinases in human cancer cells. J. Cell. Physiol., 193, 133-144.
30. Siu,M.K., Wong,E.S., Chan,H.Y., Kong,D.S., Woo,N.W., Tam,K.F., Ngan,H.Y., Chan,Q.K., Chan,D.C., Chan,K.Y. et al. (2009) Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion. Int. J. Cancer., 127, 21-31.
31. Ray-Gallet,D., Woolfe,A., Vassias,I., Pellentz,C., Lacoste,N., Puri,A., Schultz,D.C., Pchelintsev,N.A., Adams,P.D., Jansen,L.E. et al. (2011) Dynamics of histone H3 deposition in vivo reveal a nucleosome gap-filling mechanism for H3.3 to maintain chromatin integrity. Mol. Cell, 44, 928-941.
32. Shi,Y. (2009) Serine/threonine phosphatases: mechanism through structure. Cell, 139, 468-484.
33. Bollen,M., Peti,W., Ragusa,M.J. and Beullens,M. (2010) The extended PP1 toolkit: designed to create specificity. Trends Biochem. Sci., 35, 450-458.
34. Oliva-Trastoy,M., Berthonaud,V., Chevalier,A., Ducrot,C., Marsolier-Kergoat,M.C., Mann,C. and Leteurtre,F. (2007) The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase. Oncogene, 26, 1449-1458. (Pubitemid 46340814)
35. Le Guezennec,X. and Bulavin,D.V. (2009) WIP1 phosphatase at the crossroads of cancer and aging. Trends Biochem. Sci., 35, 109-114.
36. Zhang,X., Kim,J., Ruthazer,R., McDevitt,M.A., Wazer,D.E., Paulson,K.E. and Yee,A.S. (2006) The HBP1 transcriptional repressor participates in RAS-induced premature senescence. Mol. Cell. Biol., 26, 8252-8266. (Pubitemid 44748562)
37. Zhang,R., Poustovoitov,M.V., Ye,X., Santos,H.A., Chen,W., Daganzo,S.M., Erzberger,J.P., Serebriiskii,I.G., Canutescu,A.A., Dunbrack,R.L. et al. (2005) Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev. Cell, 8, 19-30. (Pubitemid 40058002)